Abstract:OBJECTIVE:To design and synthesize folate-modified pH-responsive chitosan-based nanomicelles and investigate the in vitro anti-tumor activity of the drug-loaded micelles.METHODS:CHI-DMA was obtained by reductive amination reaction of aldehyde-based chitosan and hydrophilic amine compounds, and CHI-DMA-LA was obtained by condensation reaction with lauric acid; FA-CHI-DMA-LA was obtained after modification with folic acid (FA). The drug-loaded nanomicelles FA-CHI-DMA-LA/DOX were assembled by solvent change method. The physicochemical properties of polymers were characterized by hydrogen nuclear magnetic resonance and transmission electron microscope. The particle size and surface potential were determined by dynamic light scattering method. Folic acid access rate, doxorubicin (DOX) loading rate and entrapped efficiency were measured by UV-vis spectrophotometer. The drug release properties of DOX-loaded micelles in vitro were monitored by fluorescence spectrophotometer at different pHs (7.4, 6.5, 5.0). The cytotoxicity against human oral cancer KB cells was detected by MTT assay. Fluorescence microscope and flow cytometry were applied to investigate the phagocytosis of DOX-loaded micelles on KB cells.RESULTS:FA-CHI-DMA-LA was synthesized. The particle sizes of FA-CHI-DMA-LA-1 and FA-CHI-DMA-LA-2 micelles which used for the subsequent experiments were (73±14) nm and (106±15) nm, zeta potential were (15.59±1.98) mV and (21.20±2.35) mV, respectively. The drug loading rates of drug-loaded micelles FA-CHI-DMA-LA-1/DOX and FA-CHI-DMA-LA-2/DOX are (4.08±1.12)%and (4.12±0.44)%, respectively. In vitro drug release is pH-responsive, with cumulative release of DOX up to 37%and 36%at pH 5.0, which is about 1.5 times higher than that of pH 7.4. For FA-CHI-DMA-LA micelles with 1.25 to 125 μg/mL concentration, the survival rate of KB cells is more than 70%after incubation for 24 hours. The cell uptake of FA-CHI-DMA-LA/DOX micelles was enhanced compared to CHI-DMA-LA/DOX, and the cell uptake was higher in incubation without FA medium than that with FA. Compared with free DOX or CHI-DMA-LA/DOX, FA-CHI-DMA-LA/DOX nanomicelles showed higher cyctoxicity to KB cells, especially the FA-CHI-DMA-LA-2/DOX nanomicelles, the cell survival rate was about 17% after incubation for 24 hours.CONCLUSIONS:FA-modified chitosan-based nanomicelle with good biocompatibility was successfully prepared, which exhibits tumor microenvironmental pH responsive drug release and tumor targeting.

Preparation of Folate-Aminocaproic Acid-Doxorubicin Conjugate and Its Antitumor Activity in Vitro

Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro.

Synthesis and Evaluation of a Folate-linked Anti-cancer Prodrug

In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.

Preparation and in Vitro Anti-tumor Activity Evaluation of Folate-conjugated Polymeric Micelles Loaded with Doxorubicin

A Ph-Sensitive Doxorubicin Prodrug Based on Folate-Conjugated BSA for Tumor-Targeted Drug Delivery

Folate-decorated Maleilated Pullulan–doxorubicin Conjugate for Active Tumor-Targeted Drug Delivery

Preparation and Anti-Tumor Effect in Vitro of Doxorubicin-Loaded Targeting Micelles Modified by Folic Acid

Prodrug of Folate-mediated Pullulan-doxorubicin Polymer:Preparation,Characterization and Biological Evaluation

Antitumor Activity of a Folate Receptor-Targeted Immunoglobulin G-doxorubicin Conjugate.

Synthesis of Folate Modified Chitosan-Based Nanomicelles and Its in Vitro Anti-Tumor Activity

Folate-conjugated amphiphilic block copolymers for targeted and efficient delivery of doxorubicin.

Folate‐decorated Polysaccharide‐doxorubicin Polymer: Synthesis, Characterization, and Activity in HeLa Cells

Folate-conjugated pH-responsive nanocarrier designed for active tumor targeting and controlled release of doxorubicin

The Preparation of Cationic Folic Acid and Its Application in Drug Delivery System

Doxorubicin-Loaded, Charge Reversible, Folate Modified Hpma Copolymer Conjugates for Active Cancer Cell Targeting

Folate-receptor Mediated Ph/reduction-Responsive Biomimetic Nanoparticles for Dually Activated Multi-Stage Anticancer Drug Delivery.

Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated Ph-Dependent Thermo-Sensitive Copolymer: in Vitro and in Vivo Evaluation

Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation.

Self-assembly of Folic Acid Dextran Conjugates for Cancer Chemotherapy

Antitumor Activity of a Novel Double-Targeted System for Folate Receptor-Mediated Delivery of Mitomycin C